You are here:

  1. Home
  2. NICE Guidance
  3. Conditions and diseases
  4. Blood and immune system conditions
  5. Blood and bone marrow cancers

Rituximab for the treatment of relapsed or refractory stage 3 or 4 follicular non-Hodgkin's lymphoma

  • Technology appraisal guidance
  • Reference number: TA137
  • Published:  27 February 2008
  • Guidance
  • Tools and resources
  • Information for the public
  • Evidence
  • History

Information for the public

  • Rituximab for the treatment of relapsed or refractory stage III or IV follicular non-Hodgkin's lymphoma (PDF 145 KB)

    Published:
    27 February 2008
  • Gwybodaeth i'r cyhoedd (Word 238 KB)

    Published:
    15 September 2008
Back to top